UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

                                           

FORM 8‑K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

December 15, 2014

                                           

INOGEN, INC.

(Exact name of registrant as specified in its charter)

Delaware

 

001-36309

 

33-0989359

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

326 Bollay Drive

Goleta, California 93117

(Address of principal executive offices, including zip code)

(805) 562-0500

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



Item 7.01.  Regulation FD Disclosure.

 

On December 15, 2014, Inogen, Inc. (“Inogen”) issued a news release in connection with its Investor & Analyst Day event.  A copy of the news release is attached to this Current Report on Form 8-K as Exhibit 99.1

 

The information in this Item 7.01 and in Exhibit 99.1 is furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of Inogen’s filings under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits

 

 

 

Exhibit

 

Description

 

 

99.1

 

Press Release, dated December 15, 2014.

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

INOGEN, INC.

 

 

 

 

By:

/s/Alison Bauerlein

 

 

Alison Bauerlein

Executive Vice President, Finance, Chief Financial Officer, Secretary and Treasurer

Date:  December 15, 2014



EXHIBIT INDEX

 

 

 

 

Exhibit
No.

 

Description

 

 

99.1

 

Press Release, dated December 15, 2014.